Frédéric Massé

2.3k total citations
22 papers, 1.4k citations indexed

About

Frédéric Massé is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Frédéric Massé has authored 22 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Cancer Research and 3 papers in Surgery. Recurrent topics in Frédéric Massé's work include Bone Metabolism and Diseases (9 papers), Protease and Inhibitor Mechanisms (8 papers) and Natural product bioactivities and synthesis (5 papers). Frédéric Massé is often cited by papers focused on Bone Metabolism and Diseases (9 papers), Protease and Inhibitor Mechanisms (8 papers) and Natural product bioactivities and synthesis (5 papers). Frédéric Massé collaborates with scholars based in Canada, United States and Switzerland. Frédéric Massé's co-authors include W. Cameron Black, Raphaël Roduit, Sylvie Desmarais, M. David Percival, Neil B. Ruderman, Jean‐Pierre Falgueyret, Marc Prentki, Denis Riendeau, Serge Léger and Renata M. Oballa and has published in prestigious journals such as Journal of Biological Chemistry, Diabetes and Journal of Medicinal Chemistry.

In The Last Decade

Frédéric Massé

22 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frédéric Massé Canada 18 749 361 281 222 194 22 1.4k
Christopher Lowe United Kingdom 20 727 1.0× 370 1.0× 266 0.9× 202 0.9× 136 0.7× 45 2.0k
Hariprasad Vankayalapati United States 21 1.5k 2.0× 280 0.8× 159 0.6× 115 0.5× 180 0.9× 61 2.2k
Hong Ding China 26 1.7k 2.3× 311 0.9× 94 0.3× 79 0.4× 154 0.8× 80 2.3k
Philip D. Edwards United States 24 712 1.0× 504 1.4× 144 0.5× 159 0.7× 172 0.9× 32 1.6k
Jun Ohsumi Japan 18 535 0.7× 111 0.3× 151 0.5× 147 0.7× 81 0.4× 31 1.2k
David Austin United Kingdom 19 774 1.0× 280 0.8× 164 0.6× 49 0.2× 54 0.3× 77 1.6k
Bruce A. Lefker United States 22 539 0.7× 452 1.3× 76 0.3× 129 0.6× 48 0.2× 40 1.3k
Paul E. Finke United States 23 559 0.7× 461 1.3× 311 1.1× 66 0.3× 248 1.3× 45 1.6k
Hongyan Qi China 21 926 1.2× 190 0.5× 67 0.2× 76 0.3× 312 1.6× 72 1.5k
Jun Katada Japan 20 481 0.6× 249 0.7× 122 0.4× 43 0.2× 74 0.4× 36 1.3k

Countries citing papers authored by Frédéric Massé

Since Specialization
Citations

This map shows the geographic impact of Frédéric Massé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Massé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Massé more than expected).

Fields of papers citing papers by Frédéric Massé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Massé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Massé. The network helps show where Frédéric Massé may publish in the future.

Co-authorship network of co-authors of Frédéric Massé

This figure shows the co-authorship network connecting the top 25 collaborators of Frédéric Massé. A scholar is included among the top collaborators of Frédéric Massé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédéric Massé. Frédéric Massé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Massé, Frédéric, et al.. (2016). Application of the Protein Maker as a platform purification system for therapeutic antibody research and development. Computational and Structural Biotechnology Journal. 14. 238–244. 7 indexed citations
2.
Ndao, Momar, Christian Beaulieu, W. Cameron Black, et al.. (2013). Reversible Cysteine Protease Inhibitors Show Promise for a Chagas Disease Cure. Antimicrobial Agents and Chemotherapy. 58(2). 1167–1178. 75 indexed citations
3.
Boulet, Louise, Christine Brideau, David Claveau, et al.. (2011). Trisubstituted ureas as potent and selective mPGES-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(5). 1488–1492. 22 indexed citations
4.
Beaulieu, Christian, Élise Isabel, Frédéric Massé, et al.. (2010). Identification of potent and reversible cruzipain inhibitors for the treatment of Chagas disease. Bioorganic & Medicinal Chemistry Letters. 20(24). 7444–7449. 53 indexed citations
5.
Ducharme, Yves, Marc Blouin, Christine Brideau, et al.. (2010). The Discovery of Setileuton, a Potent and Selective 5-Lipoxygenase Inhibitor. ACS Medicinal Chemistry Letters. 1(4). 170–174. 70 indexed citations
6.
Léger, Serge, W. Cameron Black, Denis Deschênes, et al.. (2009). Synthesis and biological activity of a potent and orally bioavailable SCD inhibitor (MF-438). Bioorganic & Medicinal Chemistry Letters. 20(2). 499–502. 55 indexed citations
7.
Desmarais, Sylvie, Frédéric Massé, & M. David Percival. (2009). Pharmacological inhibitors to identify roles of cathepsin K in cell-based studies: a comparison of available tools. Biological Chemistry. 390(9). 941–948. 39 indexed citations
8.
Boyd, Michael J., Sheldon N. Crane, Joël Robichaud, et al.. (2008). Investigation of ketone warheads as alternatives to the nitrile for preparation of potent and selective cathepsin K inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(3). 675–679. 23 indexed citations
9.
Robichaud, Joël, W. Cameron Black, Michel Thérien, et al.. (2008). Identification of a Nonbasic, Nitrile-Containing Cathepsin K Inhibitor (MK-1256) that is Efficacious in a Monkey Model of Osteoporosis. Journal of Medicinal Chemistry. 51(20). 6410–6420. 21 indexed citations
10.
Côté, Bernard, Louise Boulet, Christine Brideau, et al.. (2007). Substituted phenanthrene imidazoles as potent, selective, and orally active mPGES-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(24). 6816–6820. 116 indexed citations
11.
Gauthier, Jacques Yves, W. Cameron Black, Wanda Cromlish, et al.. (2007). The identification of potent, selective, and bioavailable cathepsin S inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(17). 4929–4933. 51 indexed citations
12.
Léger, Serge, Christopher I. Bayly, W. Cameron Black, et al.. (2007). Primary amides as selective inhibitors of cathepsin K. Bioorganic & Medicinal Chemistry Letters. 17(15). 4328–4332. 30 indexed citations
13.
Robichaud, Joël, Christopher I. Bayly, W. Cameron Black, et al.. (2007). β-Substituted cyclohexanecarboxamide cathepsin K inhibitors: Modification of the 1,2-disubstituted aromatic core. Bioorganic & Medicinal Chemistry Letters. 17(11). 3146–3151. 11 indexed citations
14.
Li, Chun Sing, Denis Deschênes, Sylvie Desmarais, et al.. (2006). Identification of a potent and selective non-basic cathepsin K inhibitor. Bioorganic & Medicinal Chemistry Letters. 16(7). 1985–1989. 67 indexed citations
15.
Massé, Frédéric, Sébastien Guiral, Elizabeth Cauchon, et al.. (2005). An Automated Multistep High-Throughput Screening Assay for the Identification of Lead Inhibitors of the Inducible Enzyme mPGES-1. SLAS DISCOVERY. 10(6). 599–605. 14 indexed citations
16.
Falgueyret, Jean‐Pierre, Sylvie Desmarais, Renata M. Oballa, et al.. (2005). Lysosomotropism of Basic Cathepsin K Inhibitors Contributes to Increased Cellular Potencies against Off-Target Cathepsins and Reduced Functional Selectivity. Journal of Medicinal Chemistry. 48(24). 7535–7543. 120 indexed citations
17.
Black, W. Cameron, Christopher I. Bayly, Dana Davis, et al.. (2005). Trifluoroethylamines as amide isosteres in inhibitors of cathepsin K. Bioorganic & Medicinal Chemistry Letters. 15(21). 4741–4744. 111 indexed citations
18.
Roduit, Raphaël, Christopher J. Nolan, Cristina Alarcón, et al.. (2004). A Role for the Malonyl-CoA/Long-Chain Acyl-CoA Pathway of Lipid Signaling in the Regulation of Insulin Secretion in Response to Both Fuel and Nonfuel Stimuli. Diabetes. 53(4). 1007–1019. 159 indexed citations
19.
Saha, Asish K., Raphaël Roduit, Frédéric Massé, et al.. (2000). Activation of Malonyl-CoA Decarboxylase in Rat Skeletal Muscle by Contraction and the AMP-activated Protein Kinase Activator 5-Aminoimidazole-4-carboxamide-1-β-d-ribofuranoside. Journal of Biological Chemistry. 275(32). 24279–24283. 154 indexed citations
20.
Roduit, Raphaël, Frédéric Massé, Laura Segall, et al.. (2000). Glucose Down-regulates the Expression of the Peroxisome Proliferator-activated Receptor-α Gene in the Pancreatic β-Cell. Journal of Biological Chemistry. 275(46). 35799–35806. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher Lowe Breakdown of academic impact, for papers by Hariprasad Vankayalapati Breakdown of academic impact, for papers by Hong Ding Breakdown of academic impact, for papers by Philip D. Edwards Breakdown of academic impact, for papers by Jun Ohsumi Breakdown of academic impact, for papers by David Austin Breakdown of academic impact, for papers by Bruce A. Lefker Breakdown of academic impact, for papers by Paul E. Finke Breakdown of academic impact, for papers by Hongyan Qi Breakdown of academic impact, for papers by Jun Katada
Rankless by CCL
2026